52.12000 USD
1.19
2.23%
Last update Dec 15, 3:59 PM EST
Pre-market
Day range
50.90000
53.57000
Previous close
53.31000
Open
53.53000
Access this stock data via API
Subscribe
Biomarin Pharmaceutical Inc.
52.12
1.19
2.23%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 2.9B 2.4B 2.1B 1.8B
Cost of revenue 580.2M 514.9M 483.7M 470.5M
Gross profit 2.3B 1.9B 1.6B 1.4B
Operating expense
Research & development 747.2M 746.8M 649.6M 628.8M
Selling general and admin 1.0B 937.3M 854M 759.4M
Other operating expenses
Operating income 474.2M 158.1M 46.0M -74.3M
Non operating interest income
Income 74.9M 58.3M 18.0M 10.5M
Expense 12.3M 16.7M 15.4M 14.7M
Other income expense 5.3M -10.5M 101.6M 3.8M
Pretax income 541.8M 188.6M 149.6M -75.4M
Tax provision 114.9M 20.9M 8.0M -11.3M
Net income 426.9M 167.6M 141.6M -64.1M
Basic EPS 2.3 0.9 0.8 -0.4
Diluted EPS 2.2 0.9 0.8 -0.4
Basic average shares 190.0M 187.8M 185.3M 182.9M
Diluted average shares 190.0M 187.8M 185.3M 182.9M
EBITDA 640.5M 309.7M 163.3M 55.4M
Net income from continuing op. 426.9M 167.6M 141.6M -64.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 5 hours 14 minutes

04:15
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).